LEXEO THERAPEUTICS INC
LXEO · NASDAQ
Updated at 2026-10-14 09:06:44
- Today's High
- $3.09
- Today’s Low
- $2.74
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $3.22
- Previous Close
- $3.04
- Volume
- 1.04M
- Market Cap
- $249.54M
- P/E Ratio
- --
- EPS
- $-1.15
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 345 PARK AVENUE SOUTH, NEW YORK, NY, UNITED STATES, 10010
- Country
- US
- Listing Date
- 2023-11-03
- Fiscal Year End
- December
- Shares Outstanding
- 78.52M
- CIK
- 0001907108
- Website
- www.lexeotx.com
Lexeo Therapeutics, Inc. is a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company is headquartered in New York, New York.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$28.02M
2026-03-31
$21.78M
2025-12-31
$23.11M
2025-09-30
$21.64M
Net Income
2026-06-30
-$25.86M
2026-03-31
-$20.19M
2025-12-31
-$20.91M
2025-09-30
-$20.28M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.30
2026-03-31
$-0.25
2025-12-31
$-0.27
2025-09-30
$-0.33
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$25.29M
2026-03-31
-$19.63M
2025-12-31
-$20.35M
2025-09-30
-$19.67M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $28.02M | $21.78M | $23.11M | $21.64M |
| Net Income | -$25.86M | -$20.19M | -$20.91M | -$20.28M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.30 | $-0.25 | $-0.27 | $-0.33 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$25.29M | -$19.63M | -$20.35M | -$19.67M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.